Monday, August 31, 2026

Coinbase Stock Soars 15% At Opening Bell Today

ViaNews Editorial Team

October 24, 2023

Coinbase Stock Soars 15% At Opening Bell Today

(VIANEWS) - Coinbase shares surge 15.04% to EUR88.82 Coinbase (NASDAQ: COIN) shares saw an astounding 15.04% surge to EUR88.82 at 10:01 EST Tuesday morning after four consecutive sessions of increases, riding the broad uptrend seen across NASDAQ, which currently sits at +0.27% for EUR13,0118.33. Coinbase's last closing price was EUR77.21, marking a 32.53% decrease from its 52-week high of EUR114.43. However, recent fluctuations suggest potential recovery from recent losses for Coinbase and its investors alike. Keep in mind that cryptocurrency markets can be highly unpredictable, and investors should carefully assess their risk tolerance and financial goals before making any investment decisions.

About Coinbase

Coinbase Global, Inc. is an industry-leading provider of financial infrastructure and technology for the global cryptoeconomy, established in 2012. Since 2012, they have offered comprehensive services, from offering primary accounts for consumers to marketplaces for institutions to trade crypto assets to providing developers with technology for building crypto applications. Headquartered in Wilmington, Delaware - Coinbase stands out as a pioneer of secure transactions within this expanding world of digital currencies.

Yearly Analysis

Based on Coinbase's current stock value and EBITDA, investors may want to wait before purchasing its shares. At present, Coinbase stock trades at a significant discount to its 52-week high while being significantly higher than its 52-week low - suggesting some level of volatility and uncertainty within its market. Furthermore, with an EBITDA of -751.3, this company is operating at an ongoing loss, which should raise red flags among potential investors. While operating at a loss may be normal during early growth stages of business development, investors must carefully assess each company's financial health and future potential before making investment decisions. Given these factors, investors may wish to wait for an attractive outlook before considering an investment in Coinbase. This could include more stable stock price movement or positive developments that signal an eventual turnaround for the company.

Technical Analysis

Coinbase stock price currently stands at EUR92.95, significantly exceeding both its 50-day moving average of EUR79.78 and 200-day moving average of EUR66.85 - suggesting a bullish trend has recently occurred for this stock. Noteworthy is the stock's current volume which is 11.03% below its average volume of 7,659,580; this could indicate less interest in it now and could therefore alter its price stability. Regarding its stock volatility, Coinbase's average intraday variation over the past week, month and quarter was negative 1.26%; positive 0.26%; and positive 2.68% respectively. Coinbase experienced its highest average weekly volatility amplitude during last week; 2.25% last month and 2.68% during quarter. According to the stochastic oscillator, which serves as an indicator for overbought and oversold conditions, Coinbase stock appears to be oversold (=20). This could signal that investors should purchase it as it may represent an undervalued opportunity. Overall, Coinbase appears to be on an upward trend; however, investors should remain mindful of its lower-than-average trading volume and keep close tabs on its volatility.

Quarter Analysis

According to data provided, Coinbase's current quarter sales growth is negative 49% while next quarter's is anticipated to increase by 1.9%. Year-on-year revenue growth has seen an overall decrease of 17.5% with twelve trailing months totaling 2.58B currently under their belts. Negative sales growth should be cause for alarm among investors, as it reveals decreased customer interest in the products or services being offered by a company. But an expected boost in sales growth may signal a turnaround for them in future quarters. As for revenue growth, a decline of 17.5% could be cause for alarm - particularly if it continues in the future - but it's essential to take into account current market conditions and any external influences which might be contributing to its decrease. Before making any investment decisions based on this information, investors should carefully review it alongside other financial metrics and market trends. Furthermore, tracking company performance over time against industry benchmarks may provide investors with greater insight into its financial health and potential for future growth.

Equity Analysis

Coinbase's trailing twelve months EPS stands at EUR-5.62, indicating it has not generated profits for shareholders in over twelve months - something investors may find concerning as profit generation is key for long-term business success. At -22.09%, the return on equity (ROE) for the 12 trailing months was also negative. ROE measures profitability relative to shareholder's equity; an adverse ROE suggests that management is failing in its task of using equity effectively to generate profits for shareholders. Due to these negative profitability indicators, potential investors should proceed with caution and assess all associated risks before making their investment decisions. It may be prudent to await additional financial performance indicators before taking any definitive steps toward investing.

More news about Coinbase (COIN).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com